CD
MRK icon

Chapin Davis’s Merck MRK Stock Holding History

Chapin Davis’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
15,072
+252
+2% +$29.5K 0.34% 59
2026
Q1 		$1.78M Buy
14,820
+702
+5% +$81K 0.4% 56
2025
Q4 		$1.49M Buy
14,118
+539
+4% +$50.6K 0.35% 64
2025
Q3 		$1.14M Buy
13,579
+2,822
+26% +$232K 0.28% 80
2025
Q2 		$852K Sell
10,757
-481
-4% -$38.2K 0.24% 90
2025
Q1 		$1.01M Sell
11,238
-59
-0.5% -$5.51K 0.34% 68
2024
Q4 		$1.28M Hold
11,297
– – 0.42% 54
2024
Q3 		$1.28M Buy
11,297
+283
+3% +$33.6K 0.42% 55
2024
Q2 		$1.36M Sell
11,014
-7
-0.1% -$902 0.47% 47
2024
Q1 		$1.45M Sell
11,021
-311
-3% -$38.3K 0.53% 42
2023
Q4 		$1.24M Buy
11,332
+125
+1% +$13K 0.52% 44
2023
Q3 		$1.15M Hold
11,207
– – 0.55% 49
2023
Q2 		$1.29M Sell
11,207
-20
-0.2% -$2.27K 0.61% 40
2023
Q1 		$1.19M Buy
11,227
+75
+0.7% +$8.1K 0.62% 39
2022
Q4 		$1.24M Buy
+11,152
New +$1.14M 0.72% 34

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chapin Davis's MRK Position: Q2 2026 in Review

Chapin Davis increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $29.5K and bringing the position to 15,072 shares worth $1.94M. The position accounts for 0.34% of the portfolio, ranked #59.

Chapin Davis first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chapin Davis held 15,072 shares of Merck worth $1.94M as of Q2 2026.
  • Chapin Davis bought 252 Merck shares in Q2 2026, an estimated $29.5K.
  • Merck made up 0.34% of Chapin Davis's portfolio in Q2 2026, its #59 holding.
  • Chapin Davis first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.